Is Vivani Medical, Inc. (VANI) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 20.3% / 30% | 19.3% / 30% | 0.3% / 30% | N/A | ✓ HALAL |
| DJIM | 20.3% / 33% | 19.3% / 33% | 0.3% / 33% | N/A | ✓ HALAL |
| MSCI | 46.5% / 33% | 44.2% / 33% | 0.6% / 33% | N/A | ✗ NOT HALAL |
| S&P | 20.3% / 33% | 19.3% / 33% | 0.3% / 33% | N/A | ✓ HALAL |
| FTSE | 46.5% / 33% | 44.2% / 33% | 0.6% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -265.0% | |
| Return on Assets (ROA) | -50.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$21M |
| Free Cash Flow | -$21M |
| Total Debt | $19M |
| Debt-to-Equity | 1397.5 |
| Current Ratio | 0.6 |
| Total Assets | $42M |
Price & Trading
| Last Close | $1.08 |
| 50-Day MA | $1.26 |
| 200-Day MA | $1.35 |
| Avg Volume | 320K |
| Beta | 3.4 |
|
52-Week Range
$0.91
| |
About Vivani Medical, Inc. (VANI)
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Vivani Medical, Inc. (VANI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Vivani Medical, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Vivani Medical, Inc.'s debt ratio?
Vivani Medical, Inc.'s debt ratio is 20.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 46.5%.
What are Vivani Medical, Inc.'s key financial metrics?
Vivani Medical, Inc. has a market capitalization of $86M. Return on equity stands at -265.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.